TSWM
UTHR icon

Tyler-Stone Wealth Management’s United Therapeutics UTHR Stock Holding History

Tyler-Stone Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-30
Closed -$9.56K – 908
2024
Q2 		$9.56K Buy
+30
New +$7.94K ﹤0.01% 665

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Tyler-Stone Wealth Management's UTHR Position: Q3 2024 in Review

Tyler-Stone Wealth Management sold out of United Therapeutics (UTHR) in Q3 2024, closing a stake of 30 shares — an estimated $9.56K sold.

Tyler-Stone Wealth Management first reported a position in UTHR in Q2 2024 and held it in 1 quarter. The position peaked at $9.56K in Q2 2024. 624 funds tracked by Wall St. Rank hold UTHR as of Q3 2024.

  • Tyler-Stone Wealth Management reported no remaining United Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Tyler-Stone Wealth Management sold 30 United Therapeutics shares in Q3 2024, an estimated $9.56K.
  • Tyler-Stone Wealth Management first reported a position in United Therapeutics in Q2 2024 and held it in 1 quarter.
  • Tyler-Stone Wealth Management's United Therapeutics position peaked at $9.56K in Q2 2024.
  • 624 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2024.

Based on Tyler-Stone Wealth Management's 13F filing for Q3 2024, filed 4 Nov 2024.